Chronic obstructive pulmonary disease (COPD) interferes with normal breathing and COPD flare-ups may result in more physician visits and/or hospitalizations.
The AIRFLOW-3 Clinical trial uses a catheter-based system called the Nuvaira™ Lung Denervation System to help reduce chronic obstructive pulmonary disease (COPD) flare-ups.
Targeted Lung Denervation (TLD) is a one-time non-surgical procedure that may reduce the frequency and seriousness of COPD flare-ups.
This post is also available in:
French German Dutch